X
Record #37573

Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial

Publisher
Frontiers
Original paper date
Jul 19, 2021
Institution
Applied Biology, Inc. Irvine, CA, United States · Department of Endocrinology, Corpometria Institute, Brasilia, Brazil · Dermatology Department, Ramón y Cajal Hospital, Madrid, Spain · Department of Dermatology and Venereology, University Hospital Center “Sestre Milosrdnice”, Zagreb, Croatia · Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, United States · Sinclair Dermatology, Melbourne, VIC, Australia · Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, United States · School of Medicine, European University Cyprus, Nicosia, Cyprus · Intensive Care Unit, Samel Hospital, Manaus, Brazil · Hospital da Brigada Militar, Porto Alegre, Brazil · Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, United States
Open access
No
Article type
Clinical Study
Broad categories
(HSC) Medicine - Infectious Disease(HSC) Medicine - Pharmacology
Notes from Retraction Watch

see also: https://www.bmj.com/content/375/bmj.n2819

Citation lifecycle

How this paper is being cited

Pre-retraction
24
Same day
0
Post-retraction
17
% post-retraction
41.5%
~27.1 citations/yr before retraction · ~4.0 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse